Cognitive deterioration upon admission is an important risk indicator of falls in the respiratory ward, Masafumi Nojiri, Tatsuya Watanabe, Koichi Yamamura, Saki Matsuura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Ryo Kato, Shohei Shinomiya, Yutaka Takahara, Yuki Fujimoto, Taku Oikawa, Shiro Mizuno, Physical Medicine and Rehabilitation Resarch, 5:1-5, 2020年08月
A case of ROS1-rearranged lung adenocarcinoma with osteoblastic bone metastasis, Takahara Yutaka, Yamamura Kouichi, Matsuura Saki, Sakuma Takashi, Nishiki Kazuaki, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Rieko, Fujimoto Yuki, Oikawa Taku, Osanai Kazuhiro, Ueda Yoshimichi, Mizuno Shiro, Respiratory Medicine Case Reports, 30:101124, 2020年06月
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows., Takahara Yutaka, Tanaka Takuya, Ishige Yoko, Shionoya Ikuyo, Yamamura Kouichi, Sakuma Takashi, Nishiki Kazuaki, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Fujimoto Yuki, Oikawa Taku, Mizuno Shiro, Thoracic cancer, 12:2758-2766, 2021年10月
First case of lung cancer with pneumoconiosis and endobronchial leiomyoma complicating the diagnosis., Takahara Yutaka, Yamamura Kouichi, Motono Nozomu, Oikawa Taku, Uramoto Hidetaka, Mizuno Shiro, BMC pulmonary medicine, 21:286-292, 2021年09月
Early recurrence factors in patients with stage Ⅲ non-small cell lung cancer treated with concurrent chemoradiotherapy, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno, Thorac Cancer, 13:3451-3458, 2022年12月
Differential response in patients with large cell neuroendocrine carcinoma of the lung to initial therapy: A case series, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno, Cancer Reports(Hoboken,NJ), e1754:1-8, 2022年11月
Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non-small cell lung cancer, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Yuki Fujimoto, Taku Oikawa, Shiro Mizuno, Thorac Cancer, 13:624-630, 2022年02月
Serum Derivatives of Reactive Oxygen Metabolites are Associated with Severity of Chronic Obstructive Pulmonary Disease and Affected by a P53 Gene Polymorphism, Koichi Yamamura, Masafumi Nojiri, Kazuaki Nishiki, Ryo Kato, Shohei Shinomiya, Yutaka Takahara, Taku Oikawa, Takeshi Iahizaki, Hirohisa Toga, Shiro Mizuno, International Journal of Chronic Obstructive Pulmonary Disease, 17:1589-1600, 2022年07月
Investigation of response of patients with non－small cell lung cancer to docetaxel（plus ramucirumab) therapy in second-line treatment, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, ThoracCancer, 14:3549-3555, 2023年11月
Investigation of response factors for monotherapy with immnune checkpoint inhibitors in non-small cell lung cancer patients with PD-L1 expression <50%, Yutaka Takahara, Ryudai Abe, Nagae Sumito, Takuya Tanaka, Yoko Ishige, Ikuyo Shinomiya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Takua Oikawa, Thorac Cancer, 27:2754-2760, 2023年09月
Influencing factors of efficacy and long-term use of amrubicin in patients with small cell lung cancer, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno, Thorac Cancer, 14:1286-1293, 2023年05月
Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy, Yutaka Takahara, Ryudai Abe, Nagae Sumito Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Thorac Cancer, 2024:1-7, 2024年03月
Investigation of the Efficacy of Epidermal Growth Factor Receptor（EGFR）－Tyrosine Kinase Inhibitor in Patients With Exon 21 L858R Point Mutation-Positive Non-small Cell Lung Cancer, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Masafumi Nojiri, Masaharu Iguchi, Cureus, 16:e68411, 2024年06月
